Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-21

Clinical Trial Update: Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial compared gabapentin to placebo to facilitate buprenorphine detoxification in opioid-dependent individuals; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEURONTIN (gabapentin)

Snippet

Sponsor: University of Arkansas | Conditions: Opioid Dependence, Opioid Withdrawal | Phase 2 | Status: COMPLETED | Results posted: 2013-06-21